Shanghai Fosun Pharmaceutical (group) Co., Ltd. Class ASSE: 600196

(600196)"Shanghai Fosun Pharmaceutical (Group) Co., Ltd."Announcement on Results of Reserved Grant under the 2025 A-Share Stock Option Incentive Plan

Sep 29, 2026 · Issued by Shanghai Fosun Pharmaceutical (group) Co., Ltd. Class A via Shanghai Stock Exchange

SSE: 600196

Announcement on Results of Reserved Grant under the 2025 A-Share Stock Option Incentive Plan

The abstract is for reference only. Please refer to the full text of the announcement on the very day.

Link of Full Text for Reference:
View Attachment

View original source (Shanghai Stock Exchange)

Earlier from Shanghai Fosun Pharmaceutical (group) Co., Ltd. Class A

A New International Medical Approach Aimed at Reversing Diabetes has Officially Launched in Shenzhen, ChinaSep 28
"Shanghai Fosun Pharmaceutical (Group) Co., Ltd."Announcement on Signing of Cooperation and License Agreement by Controlled SubsidiarySep 24
"Shanghai Fosun Pharmaceutical (Group) Co., Ltd."Announcement on Release of Pledge of Certain Shares Held by ShareholderSep 22
"Shanghai Fosun Pharmaceutical (Group) Co., Ltd."Announcement on Pledge and Release of Pledge on Certain Shares Held by a ShareholderSep 19

All Shanghai Fosun Pharmaceutical (group) Co., Ltd. Class A news releases